Experiences with
Daratumumab

6 public posts

CD38

Perhaps we will be hearing more about Daratumumab ( Darzalex).

Perhaps we will be hearing more about Daratumumab ( Darzalex).

in Advanced Prostate Cancer

4 years ago

New type of treatment could reawaken immune response against prostate cancer

Targeting CD38 Their study suggests that therapies which target CD38 – such as the multiple myeloma drug daratumumab – could hold promise against prostate cancer too, by reawakening the anti-cancer immune response.

Targeting CD38 Their study suggests that therapies which target CD38 – such as the multiple myeloma drug daratumumab – could hold promise against prostate cancer too, by reawakening the anti-cancer immune response.

in Advanced Prostate Cancer

4 years ago

TREATMENT UPDATE: Daratumumab (also known as Darzalex®) recommended across Europe in new combinations for myeloma patients.

The Committee of Human Medicinal Products in Europe is recommending that daratumumab (also known as Darzalex®) has its licence extended to include combination treatments for myeloma patients. It's already licensed in Europe for use on its own.

The Committee of Human Medicinal Products in Europe is recommending that daratumumab (also known as Darzalex®) has its licence extended to include combination treatments for myeloma patients. It's already licensed in Europe for use on its own.

8 years ago

Want to take advantage of all our features? Just log in!

or

SMC say “no” to Kyprolis® and Darzalex® for myeloma patients in Scotland

Scotland's drug approval body has decided not to recommend both Kyprolis® (carfilzomib) and Darzalax® (daratumumab) for myeloma patients. Myeloma UK made a strong case to the SMC and we are very disappointed by the decision.

Scotland's drug approval body has decided not to recommend both Kyprolis® (carfilzomib) and Darzalax® (daratumumab) for myeloma patients. Myeloma UK made a strong case to the SMC and we are very disappointed by the decision.

8 years ago

Can High-Risk Myeloma Patients Become Refractory to Certain Monoclonal Antibodies?

Patient Power Community member, Francis, asks “Can refractory, high-risk myeloma patients become refractory to daratumumab?” Dr.

Patient Power Community member, Francis, asks “Can refractory, high-risk myeloma patients become refractory to daratumumab?” Dr.

in Myeloma America Support

9 years ago

Daratumumab Drug Trial

Hello I was wondering if anyone has heard of a new drug (I think) called Daratumumab. There was a small piece in the newspaper (Perth WA) regarding this new drug, saying that "it has produced excellent results for patients, with an incurable blood cancer, with many expected to go into remission.

Hello I was wondering if anyone has heard of a new drug (I think) called Daratumumab. There was a small piece in the newspaper (Perth WA) regarding this new drug, saying that "it has produced excellent results for patients, with an incurable blood cancer, with many expected to go into remission.

9 years ago